CTC (Chicago Trading Company)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-167
Closed -$483K 295
2024
Q3
$483K Sell
167
-523
-76% -$15.3K ﹤0.01% 261
2024
Q2
$1.93M Sell
690
-930
-57% -$25.6K ﹤0.01% 254
2024
Q1
$4.5M Sell
1,620
-4,466
-73% -$124K ﹤0.01% 251
2023
Q4
$17.5M Sell
6,086
-546
-8% -$16.5K 0.01% 200
2023
Q3
$22M Sell
6,632
-3,680
-36% -$130K 0.01% 177
2023
Q2
$37.8M Sell
10,312
-858
-8% -$33.4K 0.02% 162
2023
Q1
$45.1M Buy
11,170
+1,445
+15% +$62.4K 0.03% 150
2022
Q4
$49.8M Buy
9,725
+112
+1% +$5.37K 0.04% 122
2022
Q3
$42M Sell
9,613
-560
-6% -$27.2K 0.03% 147
2022
Q2
$53.3M Buy
10,173
+4,269
+72% +$218K 0.03% 124
2022
Q1
$30.5M Sell
5,904
-17,648
-75% -$916K 0.01% 185
2021
Q4
$139M Buy
23,552
+20,541
+682% +$1.02M 0.06% 60
2021
Q3
$12.9M Buy
+3,011
New +$133K 0.01% 130

Other funds holding PFE

CTC (Chicago Trading Company)'s PFE Position: Q1 2025 in Review

CTC (Chicago Trading Company) sold out of Pfizer (PFE) in Q1 2025, closing a stake of 137,445 shares — an estimated $3.65M sold.

CTC (Chicago Trading Company) first reported a position in PFE in Q2 2013 and held it in 13 quarters. The position peaked at $80.6M in Q4 2021. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • CTC (Chicago Trading Company) reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • CTC (Chicago Trading Company) sold 137,445 Pfizer shares in Q1 2025, an estimated $3.65M.
  • CTC (Chicago Trading Company) first reported a position in Pfizer in Q2 2013 and held it in 13 quarters.
  • CTC (Chicago Trading Company)'s Pfizer position peaked at $80.6M in Q4 2021.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on CTC (Chicago Trading Company)'s 13F filing for Q1 2025, filed 16 May 2025.